fingolimod hydrochloride has been researched along with Infarction, Middle Cerebral Artery in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Y; Li, S; Lin, K; Lv, A; Tian, L; Wang, Z; Yan, Y; Zhao, W | 1 |
| Sui, R; Zhang, L | 1 |
| Arai, K; Esposito, E; Lee, J; Li, W; Lizasoain, I; Lo, EH; Mandeville, ET; Mandeville, JB; Moro, MÁ; Nakano, T; Park, JH; Quinto-Alemany, D; Waeber, C; Zhang, F | 1 |
| Choi, JW; Gaire, BP | 1 |
| Chen, CP; Chew, WS; Chua, XY; Herr, DR; Ho, LTY; Lai, MKP; Lam, BWS; Ong, WY; Xiang, P | 1 |
| Altay, O; Hasegawa, Y; Rolland, W; Suzuki, H; Zhang, JH | 1 |
| Haghani, M; Keshavarz, S; Namavar, MR; Nazari, M; Rafati, A | 1 |
| Fluri, F; Kleinschnitz, C; Krstic, M; Schuhmann, MK | 1 |
| Gidday, JM; Park, TS; Wacker, BK | 1 |
| Friedlander, RM; Lin, N | 1 |
| Hasegawa, Y; Rolland, W; Sozen, T; Suzuki, H; Zhang, JH | 1 |
| Czech-Zechmeister, B; Foerch, C; Huwiler, A; Koch, A; Mirceska, A; Pfeilschifter, J; Pfeilschifter, W; Rami, A; Steinmetz, H; Sujak, M | 1 |
2 review(s) available for fingolimod hydrochloride and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Sphingosine 1-Phosphate Receptors in Cerebral Ischemia.
Topics: Animals; Brain Damage, Chronic; Brain Ischemia; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Fingolimod Hydrochloride; Humans; Infarction, Middle Cerebral Artery; Inflammation; Ischemic Stroke; Lysophospholipids; Neovascularization, Physiologic; Nerve Tissue Proteins; Neuroprotective Agents; Phosphotransferases (Alcohol Group Acceptor); Rats; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors | 2021 |
Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment.
Topics: Aldehyde-Lyases; Alzheimer Disease; Animals; Cerebrovascular Disorders; Clinical Trials as Topic; Dementia, Vascular; Drug Delivery Systems; Drug Evaluation, Preclinical; Fingolimod Hydrochloride; Humans; Infarction, Middle Cerebral Artery; Inflammation; Ischemic Stroke; Lysophospholipids; Mice; Mice, Knockout; Neurodegenerative Diseases; Phosphotransferases (Alcohol Group Acceptor); Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors | 2021 |
10 other study(ies) available for fingolimod hydrochloride and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
USPIO-SWI Shows Fingolimod Enhanced Alteplase Action on Angiographic Reperfusion in eMCAO Rats.
Topics: Animals; Contrast Media; Dextrans; Embolism; Fingolimod Hydrochloride; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Rats; Reperfusion; Stroke; Tissue Plasminogen Activator | 2022 |
Fingolimod protects against cerebral ischemia reperfusion injury in rats by reducing inflammatory cytokines and inhibiting the activation of p38 MAPK and NF-κB signaling pathways.
Topics: Animals; Cerebral Cortex; Fingolimod Hydrochloride; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Interleukins; Male; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2022 |
Fingolimod Does Not Reduce Infarction After Focal Cerebral Ischemia in Mice During Active or Inactive Circadian Phases.
Topics: Animals; Brain Edema; Brain Ischemia; Disease Models, Animal; Fingolimod Hydrochloride; Hemorrhage; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Sphingosine; Stroke | 2022 |
Role of the sphingosine metabolism pathway on neurons against experimental cerebral ischemia in rats.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Fingolimod Hydrochloride; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Male; Neurons; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Rats; Rats, Sprague-Dawley; Sphingosine | 2013 |
Fingolimod (FTY720) improves hippocampal synaptic plasticity and memory deficit in rats following focal cerebral ischemia.
Topics: Animals; Avoidance Learning; Brain Infarction; Disease Models, Animal; Fingolimod Hydrochloride; Hippocalcin; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Long-Term Potentiation; Lymphocytes; Male; Memory Disorders; Neurologic Examination; Neuronal Plasticity; Neutrophils; Rats; Rats, Sprague-Dawley; Reperfusion; Time Factors | 2016 |
Fingolimod (FTY720) Reduces Cortical Infarction and Neurological Deficits During Ischemic Stroke Through Potential Maintenance of Microvascular Patency.
Topics: Animals; Brain; Brain Infarction; Brain Ischemia; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Fingolimod Hydrochloride; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Microvessels; Stroke | 2016 |
Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2.
Topics: Animals; Arterioles; Brain Edema; Cerebral Arteries; Cerebrovascular Circulation; Disease Models, Animal; Fingolimod Hydrochloride; Hypoxia-Ischemia, Brain; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Ischemic Preconditioning; Lysophospholipids; Male; Mice; Microcirculation; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Reperfusion Injury; RNA, Messenger; Sphingosine | 2009 |
T-cell activation in ischemic stroke: a new therapeutic target for delayed infarct expansion?
Topics: Animals; Brain Infarction; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Immunosuppressive Agents; Infarction, Middle Cerebral Artery; Interleukin-17; Interleukin-23; Mice; Mice, Knockout; Propylene Glycols; Sphingosine; T-Lymphocytes | 2009 |
Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Fingolimod Hydrochloride; Immunosuppressive Agents; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; MAP Kinase Signaling System; Nerve Degeneration; Neuroprotective Agents; Oxadiazoles; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingosine; Stroke; Thiophenes; Treatment Outcome | 2010 |
Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia.
Topics: Animals; Brain Ischemia; Enzyme Activation; Fingolimod Hydrochloride; Gene Deletion; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Sphingosine | 2011 |